引用本文:许美蓉.输血前11606例患者HIV和HCV及TP抗体检测结果分析[J].中国临床新医学,2012,5(3):240-241.
【打印本页】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1683次   下载 1193 本文二维码信息
码上扫一扫!
分享到: 微信 更多
输血前11606例患者HIV和HCV及TP抗体检测结果分析
许美蓉
530023 广西,南宁市第四人民医院检验科
摘要:
[摘要] 目的 为避免因输血传播疾病引起医疗纠纷和防止职业感染。方法 采用酶联免疫吸附试验对2010-01~2011-03 11 606例就医患者进行输血前人类免疫缺陷病毒(HIV)抗体、丙型肝炎病毒(HCV)抗体、梅毒螺旋体(TP)抗体三项指标筛查。结果 共检出阳性例数856例。结论 患者输血前进行三项感染性指标检测,对诊断和预防医患交叉感染、减少医疗纠纷的发生具有重要意义。
关键词:  HIV抗体  HCV抗体  TP抗体
DOI:10.3969/j.issn.1674-3806.2012.03.20
分类号:R 51
基金项目:
Analysis of the determination of serum HIV antibody, HCV antibody, TP antibody in 11606 patients before blood transfusion
XU Mei-rong
Department of Clinical Laborarories, the Fourth People′s Hospital of Nanning, Guangxi 530023, China
Abstract:
[Abstract] Objective To avoid medical dispute caused by transfusion-transmitted diseases and prevent occupational infection.Methods Serum HIV antibody, HCV antibody and TP antibody were detected by enzyme-linked immunosorbent assay (ELISA) in 11 606 patients before blood transfusion from January 2010 to March 2011. Results The positive results of above three indicators were found in 856 patients.Conclusion The detection of above three indicators before blood transfusion are important in the diagnosis and prevention of cross-infection between doctors and patients and reduction of the incidence of medical dispute.
Key words:  HIV antibody  HCV antibody  TP antibody